MedPath

A study to compare the effectiveness of suprascapular nerve block versus subacromial steroid injection in shoulder impingement syndrome.

Phase 4
Completed
Conditions
Health Condition 1: M754- Impingement syndrome of shoulderHealth Condition 2: null- Patients suffering from shoulder impingement syndrome
Registration Number
CTRI/2017/08/009550
Lead Sponsor
IPGMER SSKM Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

(1) Clinically suggestive and USG and/or MRI confirming Neer Stage I & II impingement.

(2) Not sufficiently responding to conservative treatment over 8weeks.

(3) Aged 20 to 60 years.

(4) Pain defined as a score of 5 points or more on a 10-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain).

(5) Patient mentally sound enough to communicate and participate in the study and can understand the parameters well.

Exclusion Criteria

1. USG showing Rotator cuff tear.

2. Bleeding or clotting disorders.

3. Patients refusing intervention or participation.

4. The presence of another obvious associated cause for the pain (i.e., Primary osteoarthritis of glenohumeral joint, fracture, radiculopathy, myofascial pain, central neuropathic pain)

5. Severe motor weakness (muscle power of deltoid less than grade 2 on the manual muscle test).

6. Patients with Post myocardial infarction, Post stroke, Post mastectomy, prolonged immobilization.

7. The presence of an unstable medical condition or a known uncontrolled systemic disease, including cancer, diabetes, rheumatoid arthritis, endocrine disease,

major depression, schizophrenia, & patients with persistent very high level of ESR & CRP.

8. Patients with contraindications of steroid injections i.e. overlying soft tissue sepsis, bacteraemia, anatomic inaccessibility, uncooperative patient, uncontrolled bleeding diathesis etc.

9. Patients who got intra-articular injection in shoulder within last six months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath